Tapinarof, a stilbene, is the first presumed AHR ligand in clinical use for the treatment of psoriasis and atopic dermatitis (Bobonich et al, 2023), albeit its structure makes it unlikely to be a direct AHR ligand. The gene discussed is AHR; the disease is atopic eczema.